Viropro Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2006
2007
2008
2009
2010
Sales/Revenue
-
264.00
-
-
571.10
Cost of Goods Sold (COGS) incl. D&A
96.50
108.80
-
55.50
27.50
Gross Income
96.50
155.20
-
55.50
543.60
SG&A Expense
4,338.80
1,930.90
383.10
824.00
1,251.50
Unusual Expense
-
-
363.60
48.40
-
Non Operating Income/Expense
-
52.00
66.00
3.30
-
Interest Expense
-
826.90
584.20
637.10
13.60
Pretax Income
4,435.40
2,654.60
1,734.60
1,464.90
1,010.10
Consolidated Net Income
4,435.40
2,654.60
1,734.60
1,464.90
1,010.10
Net Income
4,435.40
2,654.60
1,734.60
1,464.90
1,010.10
Net Income After Extraordinaries
4,435.40
2,654.60
1,734.60
1,464.90
1,010.10
Net Income Available to Common
4,435.40
2,654.60
1,734.60
1,464.90
1,010.10
EPS (Basic)
0.18
0.08
0.04
0.01
0.01
Basic Shares Outstanding
24,233.10
34,791.60
36,928.20
109,165.90
247,537.70
EPS (Diluted)
0.18
0.08
0.05
0.01
0.00
Diluted Shares Outstanding
24,233.10
34,791.60
36,928.20
109,165.90
247,537.70
EBITDA
4,338.80
1,666.90
790.30
824.00
969.00
Other Operating Expense
-
-
469.70
-
288.60

About Viropro

View Profile
Address
2151 O'Toole Avenue
San Jose California 95131
United States
Employees -
Website http://www.viropro.net
Updated 07/08/2019
Operates as a biopharmaceutical company .